We are offering the COVID-19 vaccine to eligible patients based on state and federal guidelines, and as supplies allow. Please do not call us for a vaccine appointment. We are notifying patients individually when they can schedule. Create a MyChart account so we can notify you. Learn more about the COVID-19 vaccine.
Kidney disease is a serious threat to public health. An estimated 30 million Americans — 13 percent of the population — have chronic kidney disease, which often leads to kidney failure that is diagnosed in more than 100,000 US residents annually. With the population aging, end-stage renal disease (ESRD) is increasing dramatically and diabetes is the single biggest cause of this problem. While advanced treatments and improved dialysis technology have extended survival over the past 20 years, more people are living with this debilitating and costly disease than ever. Their best hope is research.
Source: National Institute of Diabetes, Digestive & Kidney Diseases; American Society of Nephrology
NYU Winthrop scientists conduct research that is placing the Hospital at the cutting edge of new advances in nephrology. Their work covers a wide range of areas, including renal physiology, renal cell biology, refractory hypertension, ESRD, electrolyte disorders, hyponatremia and renal artery stenosis.
John Maesaka M.D.